Trials / Completed
CompletedNCT05514834
BCT-HA Kit for Dehydrated and Wrinkled Skin
Feasibility Study to Evaluate the Safety and Efficacy of Cellular MAtrix™ BCT-HA Kit as a New Treatment Option for Dehydrated and Wrinkled Skin (A Clinical and Histological Evaluation)
- Status
- Completed
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 15 (actual)
- Sponsor
- University of Minnesota · Academic / Other
- Sex
- All
- Age
- 30 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
This study will assess the efficacy of Cellular MatrixTM BCT-HA Kit treatment compared to placebo condition on revitalization and skin rejuvenation on the midface. Particular attention will be made to the safety aspects, as well as the histological consequences of treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Cellular Matrix TM BCT-HA Kit (ref. BCT-HA-3) | Injections with platelet-rich plasma and hyaluronic acid |
| OTHER | PRP Only | platelet rich plasma without hyaluronic acid |
| OTHER | Placebo | Neither PRP nor hyaluronic acid |
Timeline
- Start date
- 2022-06-10
- Primary completion
- 2023-10-01
- Completion
- 2024-02-29
- First posted
- 2022-08-24
- Last updated
- 2024-04-29
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05514834. Inclusion in this directory is not an endorsement.